Pancreatic Ductal Adenocarcinoma Latest Advances
Find the Latest Research About Pancreatic Ductal Adenocarcinoma
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7677 publications
Diagnostic and prognostic significance of RAC3 expression in pancreatic ductal adenocarcinoma: an Immunohistochemical analysis.
Journal: Journal of immunoassay & immunochemistry
Published: October 31, 2026
Erratum: [Corrigendum] Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis.
Journal: Oncology letters
Published: October 30, 2026
Anatomy-informed CT Spatial Phenotype Associated with Extrapancreatic Perineural Invasion in Resected Pancreatic Ductal Adenocarcinoma.
Journal: Radiology. Artificial intelligence
Published: October 28, 2026
Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma.
Journal: Nature medicine
Published: October 27, 2026
HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α.
Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026
Recovery to Intended Oncologic Therapy After Upfront Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Journal: The American surgeon
Published: October 24, 2026
Revisiting chronic pancreatitis as a risk factor for pancreatic ductal adenocarcinoma: toward precision risk stratification.
Journal: Expert review of gastroenterology & hepatology
Published: October 16, 2026
Toward Clinically Actionable Prediction of Recurrence and Metastatic Progression in Pancreatic Ductal Adenocarcinoma: A Systematic Review.
Journal: JCO clinical cancer informatics
Published: October 13, 2026
ASO Visual Abstract: Radical Antegrade Modular Pancreatosplenectomy Versus Standard Resection in T3 Body and Tail Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Cohort Study.
Journal: Annals of surgical oncology
Published: October 12, 2026
Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 12, 2026
ASO Visual Abstract: Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma.
Journal: Annals of surgical oncology
Published: October 10, 2026
Correction: Evaluating Tumor Regression and Survival Outcomes in Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment according to CAP Grading System: Clinical Usefulness and Limitations.
Journal: Annals of surgical oncology
Published: October 08, 2026
Last Updated: 11/08/2026